ITGB4 and non-small cell lung carcinoma: The impact of ITGB4 knockout on the survival of the IMA cell line NCI–H292 surpassed that observed in NSCLC, underscoring ITGB4's potential as a therapeutic target for IMA (Fig. 1N).